181 filings
Page 8 of 10
8-K
m75w2u
13 Sep 10
Rexahn Pharmaceuticals Announces the Appointment of Peter Brandt and Richard Kivel to Board of Directors
12:00am
8-K
w0khfz timq
10 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
8l466fsys
1 Jul 10
Rexahn Closes $10 Million in Registered Direct Offering
12:00am
8-K
8ywed
29 Jun 10
Rexahn to Raise $10 Million in Registered Direct Offering
12:00am
8-K
s2p3a14i1mgxw
16 Jun 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yoi5d0otaosdwd
16 Apr 10
Statistical Significance Achieved on MADRS Change from Baseline (p < 0.041) in Subgroup Analysis of Severe Patients
12:00am
8-K
sv5 39c60kj
26 Mar 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
scqdic13issgwowa8d5x
26 Oct 09
Rexahn Pharmaceuticals Announces Closing of Public Equity Offering
12:00am
8-K
srtw cq6hxwfdfj
20 Oct 09
Rexahn To Raise $5 Million in Registered Direct Offering
12:00am
8-K
t80pgd43 dj13l
21 Sep 09
Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Close on a License Agreement
12:00am
8-K
wrcms011
10 Aug 09
Entry into a Material Definitive Agreement
12:00am
8-K
cxgeos2g eqgjl15
8 Jul 09
Other Events
12:00am
8-K
l37l52j5y42
30 Jun 09
Rexahn Pharmaceuticals Signs Development and Commercialization Agreement with a Top 20 Pharmaceutical Company for Novel Anti-cancer Compound
12:00am
8-K
zam2z6
8 Jun 09
Rexahn Pharmaceuticals Announces Closing of Public Equity Offering
12:00am
8-K
jct7d k69yoqa6
20 May 09
Rexahn Pharmaceuticals Announces $10 Million Public Equity Offering
12:00am
8-K
2zenx4z
5 May 09
Rexahn Receives Acceptance of Compliance Plan by NYSE Amex
12:00am
8-K
3jksikt
15 Apr 09
Rexahn Signs Letter of Intent to Receive up to $8.55 Million for Serdaxin™ Studies
12:00am
8-K/A
t5x zc4l5z0h
2 Mar 09
Changes in Registrant's Certifying Accountant
12:00am
8-K
u5roa8wsql9j3trrwf
27 Feb 09
Rexahn Pharmaceuticals Receives Notice from NYSE Alternext US LLC
12:00am
8-K
fh8uj fj9d
23 Feb 09
Changes in Registrant's Certifying Accountant
12:00am